Literature DB >> 10461700

Syndrome of inappropriate secretion of antidiuretic hormone in malignancy.

A M Keenan1.   

Abstract

OBJECTIVES: To provide a review of pathophysiology, epidemiology, signs and symptoms, diagnosis, treatment, and nursing management of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignancy. DATA SOURCES: Research reports, review articles, and book chapters relevant to SIADH.
CONCLUSIONS: The principle cause of hyponatremia in malignancy is SIADH. Early recognition and prompt treatment can prevent serious neurologic sequelae. Antineoplastic therapy and methods to correct hyponatremia constitute effective treatment strategies. IMPLICATIONS FOR NURSING PRACTICE: Nurses play a major role in nursing assessment, appropriate interventions and symptom control, and promoting resolution of problems and optimal quality of life in patients with malignancy complicated by SIADH.

Entities:  

Mesh:

Year:  1999        PMID: 10461700     DOI: 10.1016/s0749-2081(99)80003-5

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  3 in total

1.  Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients.

Authors:  R Berardi; M Caramanti; M Castagnani; S Guglielmi; F Marcucci; A Savini; F Morgese; S Rinaldi; C Ferrini; M Tiberi; M Torniai; F Rovinelli; I Fiordoliva; A Onofri; S Cascinu
Journal:  Support Care Cancer       Date:  2015-03-05       Impact factor: 3.603

2.  The Incidence of Hyponatraemia and Its Effect on the ECOG Performance Status among Lung Cancer Patients.

Authors:  Amitabha Sengupta; Sourindra Nath Banerjee; Nirendra Mohan Biswas; Debraj Jash; Kaushik Saha; Arnab Maji; Ankan Bandyopadhyaya; Sandip Agarwal
Journal:  J Clin Diagn Res       Date:  2013-08-01

3.  Effects of arginine vasopressin on the urine proteome in rats.

Authors:  Manxia An; Yanying Ni; Xundou Li; Youhe Gao
Journal:  PeerJ       Date:  2017-05-23       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.